Expert Practice in Breast Cancer

17. 10. 2009 - 17. 10. 2009, Radisson SAS Hotel, Amsterdam, Netherlands


Friday, 16 October 2009
20:00-22:30 Welcome Reception and Buffet Dinner

Saturday, 17 October 2009
08:45-09:00 Welcome, Introduction and Demographics
C. van de Velde, MD, PhD
B. Pajk, MD

09:00-09:30 Adjuvant Endocrine Therapy in 2009: Incorporating Data from SABCS and St Gallen into Daily Clinical Practice
C. van de Velde, MD, PhD

09:30-10:00 Case #1—Adjuvant Endocrine Therapy for a Postmenopausal Patient at Intermediate Risk of Recurrence
D. Kieback, MD, PhD

10:00-10:05 Questions and Answers

10:05-10:35 Case #2—Exploring the Role of Non-Anthracycline Regimens in Early Breast Cancer
A. Llombart, MD

10:35-10:40 Questions and Answers

10:40-11:00 Break

11:00-11:30 Case #3—The Use of Gene Expression Profiles in Node-Negative Endocrine-Responsive Early Breast Cancer
B. Kaufman, MD

11:30-11:35 Questions and Answers

11:35-12:05 Case #4—Perimenopausal Breast Cancer: What is the Optimal Therapy?
D. Kieback, MD, PhD

12:05-12:10 Questions and Answers

12:10-12:40 Case #5—Targeted Therapy for HER2 Overexpressing Metastatic Breast Cancer
F. André, MD, PhD

12:40-12:45 Questions and Answers

12:45-13:45 Lunch

13:45-14:15 Case #6—Management of Metastatic Breast Cancer with Disease Progression Following Treatment with an Anthracycline and Taxane
B. Kaufman, MD

14:15-14:20 Questions and Answers

14:20-14:50 Case #7—Management of Endocrine-Responsive Metastatic Breast Cancer
A. Llombart, MD

14:50-14:55 Questions and Answers

14:55-15:25 Case #8—Current Management of Recurrent Triple-Negative Breast Cancer: What’s the Best Approach?
F. André, MD, PhD

15:25-15:30 Questions and Answers

15:30 Concluding Remarks
C. van de Velde, MD, PhD


  • Sdílejte na:
    • Facebook
    • Twitter
    • Digg
    • Google
    • Reddit
    • StumbleUpon
    • Live